BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6290930)

  • 1. Clinical toxicity of combined modality treatment with nitrosourea derivatives for central nervous system tumors.
    Robustelli della Cuna G; Paoletti P; Bernardo G; Knerich R; Butti G; Cuzzoni Q
    Neurosurgery; 1982 Sep; 11(3):408-11. PubMed ID: 6290930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study.
    Hansen HH; Selawry OS; Pajak TF; Spurr CL; Falkson G; Brunner K; Cuttner J; Nissen NI; Holland JF
    Cancer; 1981 Jan; 47(1):14-8. PubMed ID: 7006789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), NSC #4366650 and cryopreserved autologous marrow transplantation for refractory cancer. A phase I-II study.
    Phillips GL; Fay JW; Herzig GP; Herzig RH; Weiner RS; Wolff SN; Lazarus HM; Karanes C; Ross WE; Kramer BS
    Cancer; 1983 Nov; 52(10):1792-802. PubMed ID: 6354414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary fibrosis subsequent to high doses of CCNU for chronic myeloid leukemia.
    Cordonnier C; Vernant JP; Mital P; Lange F; Bernaudin JF; Rochant H
    Cancer; 1983 May; 51(10):1814-8. PubMed ID: 6572542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of brain giomas with high dose of CCNU and autologous bone marrow transplantation.
    Hildebrand J; Badjou R; Collard-Ronge E; Delforge A; Malarme M; Spiro T; Sztern B; Vandensteene A; Stryckmans PA
    Biomedicine; 1980 May; 32(2):71-5. PubMed ID: 6992877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-agent chemotherapy of brain tumors. A five-year review.
    Wilson CB; Gutin P; Boldrey EB; Drafts D; Levin VA; Enot KJ
    Arch Neurol; 1976 Nov; 33(11):739-44. PubMed ID: 185991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme.
    Solero CL; Monfardini S; Brambilla C; Vaghi A; Valagussa P; Morello G; Bonadonna G
    Cancer Clin Trials; 1979; 2(1):43-8. PubMed ID: 229983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
    Stolinsky DC; Bull FE; Pajak TF; Bateman JR
    Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors.
    Levin VA; Kabra PA; Freeman-Dove MA
    Cancer Chemother Pharmacol; 1978; 1(4):233-42. PubMed ID: 750110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU.
    Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ
    J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT; Siemann DW
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant gliomas treated after surgery by combination chemotherapy and delayed radiation therapy. Part II. Tolerance to irradiation after chemotherapy.
    Poisson M; Hauw JJ; Pouillart P; Bataini JP; Mashaly R; Pertuiset BF; Metzger J
    Acta Neurochir (Wien); 1979; 51(1-2):27-42. PubMed ID: 532726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [On the therapy of lymphogranuloma. CCNU (1(2-chlorethyl)-3-cyclohexyl-1-nitrosourea) and BCNU (1,3-bis(2-chlorethyl)-1-nitrosourea) as well as BCNU combinations in Hodgkin's lymphogranuloma, stage 3 and 4].
    Brunner KW; Maurice P; Sonntag RW
    Schweiz Med Wochenschr; 1972 Oct; 102(43):1546-51. PubMed ID: 4647016
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of advanced malignancy with CCNU (NSC 79037): a phase II cooperative study with long-term follow up.
    Cruz AB; Metter G; Armstrong DM; Aust JB; Fletcher WS; Wilson WL; Richardson JD
    Cancer; 1976 Sep; 38(3):1069-76. PubMed ID: 953955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nervous system tumors of childhood treated with CCNU, vincristine, and radiation.
    Ward HW
    Med Pediatr Oncol; 1978; 4(4):315-20. PubMed ID: 723796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of specific-locus and dominant lethal mutations in male mice by 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU).
    Ehling UH; Adler ID; Favor J; Neuhäuser-Klaus A
    Mutat Res; 1997 Oct; 379(2):219-31. PubMed ID: 9357551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcoma.
    Maurice P; Glidewell O; Jacquillat C; Silver RT; Carey R; Pas AT; Cornell CJ; Burningham RA; Nissen NI; Holland JF
    Cancer; 1978 May; 41(5):1658-63. PubMed ID: 348294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation plus adjuvant CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) vs CCNU, hpydroxyurea and vincristine in the treatment of malignant glioma.
    Costanza M; Buechler M; Munzenreider J; Emami B; Mukherji B; Shucart W; Scott M; Nathanson L; Rudders R; Stein B; Post K; Piro A
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1589-92. PubMed ID: 231595
    [No Abstract]   [Full Text] [Related]  

  • 19. 5-Fluorouracil, 1,3-bis(2-chloroethyl)-1-nitrosourea, and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea: effect on the human granulopoietic system.
    Lohrmann HP; Lepp KA; Schreml W
    J Natl Cancer Inst; 1982 Apr; 68(4):541-7. PubMed ID: 6951071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of nitrosoureas: comparison of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) after oral and intravenous administration to rats.
    Russo RG; Cattaneo MT; Bartosek I
    Tumori; 1984 Dec; 70(6):499-502. PubMed ID: 6531792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.